A

ARCH Venture Partners

54 employees

ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.

Investor insights

Countries invested in

united states7

Sectors invested in

Biotechnology235
Health Care143
Therapeutics105
Medical79
Pharmaceutical63
Life Science57
Biopharma43
Genetics22
Software21
Manufacturing21
Health Diagnostics19
Chemical14
Nanotechnology14
Agriculture11
Medical Device10
Wellness9
Semiconductor9
CRISPR9
Neuroscience9
Machine Learning8

Funding rounds participated in

$29M sweet spot round size

Most of their 381 investments are in rounds between $13M and $55M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Financial Services
Finance
Venture Capital

Date founded

1986

Investments made

L

Lightcast Discovery raised $49M on August 17, 2023

Investors: LONGWALL VENTURE PARTNERS LLP, OMX Ventures, Illumina Ventures, M Ventures and ARCH Venture Partners

U

Undisclosed raised $145M on June 7, 2023

Investors: Koch Disruptive Technologies, GV and ARCH Venture Partners

O

OncoResponse Inc. raised $14M on May 18, 2023

Investors: RiverVest Venture Partners, INTERVEST-Mortgage Investment Co., 3B Future Health Fund, Canaan, Takeda UK Limited, Bering Capital and ARCH Venture Partners

M

Myeloid Therapeutics raised $73M on May 18, 2023

Investors: Newpath Partners, 8VC and ARCH Venture Partners

O

Orbital Therapeutics raised $270M on April 26, 2023

Investors: Heritage Medical Systems, Newpath Partners, Redmile Group, Casdin Capital, LLC, Exor N.V., iGlobe Partners, The Invus Group and ARCH Venture Partners

R

Recuro Health raised $47M on April 11, 2023

Investors: The Flippen Group, 4D Capital and ARCH Venture Partners

R

Rapport Therapeutics raised $100M on March 7, 2023

Investors: Third Rock Ventures and ARCH Venture Partners

V

Volastra Therapeutics raised $60M on March 7, 2023

Investors: Polaris Partners, -, Catalio Capital Management, Vida Ventures, LLC and ARCH Venture Partners

P

Paratus Sciences raised $100M on February 27, 2023

Investors: ClavystBio, Polaris Partners, Leaps by Bayer and ARCH Venture Partners

I

IngredientWerks raised undisclosed on February 15, 2023

Investors: Open Prairie Ventures and ARCH Venture Partners

FAQ